Ocular Therapeutix, Inc. (OCUL)

7.78 +0.75 (+10.67%) USD  |  NASDAQ  |  Feb 20, 16:00
7.68 -0.10 (-1.29%) After-Hours: 20:00
More

Ocular Therapeutix Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
EyePoint Plc Upgrade
Vertex Pharmaceuticals, Inc. Upgrade